πŸ‡ΊπŸ‡Έ FDA
Patent

US 10654834

Non-systemic TGR5 agonists

granted A61KA61K45/06A61P

Quick answer

US patent 10654834 (Non-systemic TGR5 agonists) held by VENENUM BIODESIGN, LLC expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VENENUM BIODESIGN, LLC
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K45/06, A61P, A61P3/10, A61P35/00